Ultramicronized Palmitoylethanolamide for Smell, Taste in Children With Autism Spectrum Disorder. | MicrobiomeTrials← Back to trialsNCT07631455
Ultramicronized Palmitoylethanolamide for Smell, Taste in Children With Autism Spectrum Disorder.
CompletedNAINTERVENTIONAL
Trial Details
Start: 2024-04-01Est. Completion: 2024-10-30
Enrollment target: 80 participants Locations- CPR in Movimento, Latina, Italy
Other microbiome trials you might be interested in
Autism Disorder
This study aims to identify ankle structural and functional profiles associated with sensory responsiveness and toe walk…
Multiple LocationsEst. completion Aug 1, 2027
Autism Spectrum Disorder
This is a single-center, randomized, double-dummy, triple-blind, placebo-controlled, three-arm parallel-group superiorit…
Shenzhen, ChinaEst. completion Dec 31, 2026
During a previous therapeutic trial, investigators showed that the bumetanide improved significantly autism. This trial …
Limoges, FranceCompleted Dec 2019